Refractec's ViewPoint System May Provide Alternative To LASIK Surgery
This article was originally published in The Gray Sheet
Executive Summary
FDA's Ophthalmic Devices Panel review of Refractec's ViewPoint conductive keratoplasty system to treat spherical hyperopia in patients over 40 has been rescheduled for Nov. 30.